These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1563835

  • 1. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells.
    Bradshaw TD, Gescher A, Pettit GR.
    Int J Cancer; 1992 Apr 22; 51(1):144-8. PubMed ID: 1563835
    [Abstract] [Full Text] [Related]

  • 2. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C, Gescher A, Bradshaw TD, Pettit GR.
    Int J Cancer; 1994 Feb 15; 56(4):585-92. PubMed ID: 8112895
    [Abstract] [Full Text] [Related]

  • 3. Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells.
    Dale IL, Gescher A.
    Int J Cancer; 1989 Jan 15; 43(1):158-63. PubMed ID: 2910827
    [Abstract] [Full Text] [Related]

  • 4. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A, Akerman K, Heikkilä J.
    J Cell Physiol; 1993 May 15; 155(2):301-12. PubMed ID: 8482723
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
    Dale IL, Bradshaw TD, Gescher A, Pettit GR.
    Cancer Res; 1989 Jun 15; 49(12):3242-5. PubMed ID: 2720677
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
    Boorne AJ, Donnelly N, Schrey MP.
    Breast Cancer Res Treat; 1998 Mar 15; 48(2):117-24. PubMed ID: 9596483
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE.
    Cancer Res; 1992 Mar 01; 52(5):1278-83. PubMed ID: 1737390
    [Abstract] [Full Text] [Related]

  • 8. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
    Mackanos EA, Pettit GR, Ramsdell JS.
    J Biol Chem; 1991 Jun 15; 266(17):11205-12. PubMed ID: 1904062
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
    Courage C, Budworth J, Gescher A.
    Br J Cancer; 1995 Apr 15; 71(4):697-704. PubMed ID: 7710931
    [Abstract] [Full Text] [Related]

  • 10. Involvement of phospholipase D and protein kinase C in phorbol ester and fatty acid stimulated turnover of phosphatidylcholine and phosphatidylethanolamine in neural cells.
    Cook HW, Ridgway ND, Byers DM.
    Biochim Biophys Acta; 1998 Feb 05; 1390(1):103-17. PubMed ID: 9487144
    [Abstract] [Full Text] [Related]

  • 11. Differential inhibition by staurosporine of phorbol ester, bryostatin and okadaic acid effects on mouse skin.
    Gschwendt M, Kittstein W, Lindner D, Marks F.
    Cancer Lett; 1992 Sep 30; 66(2):139-46. PubMed ID: 1394118
    [Abstract] [Full Text] [Related]

  • 12. The effect of fetal calf serum on growth arrest caused by activators of protein kinase C.
    Bradshaw TD, Gescher A, Pettit GR.
    Int J Cancer; 1991 Apr 01; 47(6):929-32. PubMed ID: 1707036
    [Abstract] [Full Text] [Related]

  • 13. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
    Clarke H, Ginanni N, Laughlin KV, Smith JB, Pettit GR, Mullin JM.
    Exp Cell Res; 2000 Nov 25; 261(1):239-49. PubMed ID: 11082294
    [Abstract] [Full Text] [Related]

  • 14. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells.
    Jalava A, Lintunen M, Heikkilä J.
    Biochem Biophys Res Commun; 1993 Mar 15; 191(2):472-8. PubMed ID: 8461005
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase C agonist and antagonist effects in normal human epidermal keratinocytes.
    Matsui MS, Illarda I, Wang N, DeLeo VA.
    Exp Dermatol; 1993 Dec 15; 2(6):247-56. PubMed ID: 8162345
    [Abstract] [Full Text] [Related]

  • 16. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE.
    Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938
    [Abstract] [Full Text] [Related]

  • 17. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL, May WS, Tyler PG, Hess AD.
    J Immunol; 1991 Nov 15; 147(10):3474-81. PubMed ID: 1834742
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG, Grunicke D, Drexler HG.
    Invest New Drugs; 1994 Nov 15; 12(1):15-23. PubMed ID: 7960600
    [Abstract] [Full Text] [Related]

  • 20. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
    Gschwend JE, Fair WR, Powell CT.
    Mol Pharmacol; 2000 Jun 15; 57(6):1224-34. PubMed ID: 10825394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.